抑郁症治疗药物经济学研究进展  

Progress in pharmacoeconomics of depression treatment

作　　者：陈学镔 王建伟[1] 孙国君[1] CHEN Xuebin;WANG Jianwei;SUN Guojun(College of Pharmaceutical Science,Zhejiang University of Technology,Huzhou 313200,China)

机构地区：[1]浙江工业大学药学院,湖州313200

出　　处：《上海医药》2024年第13期57-61,共5页Shanghai Medical & Pharmaceutical Journal

摘　　要：抑郁症是现在最常见的一种心理疾病,治疗抑郁症的药物种类繁多。本文就抑郁症治疗药物的经济学研究进展进行综述,以近10年国内外已有相关文献为基础,成本-效果分析结果为主要依据,对不同类别药物内部或药物之间进行药物经济学研究分析。研究总结了不同类别治疗药物的经济性差别,以期为临床医生在选取安全、有效和经济的治疗方案时提供参考。Depression is now the most common psychological disorder,and there are a wide variety of drugs for the treatment of depression.This article reviews the research progress of pharmacoeconomics in the treatment of depression and analyzes the pharmacoeconomic research within or between different classes of drugs based on the relevant literature available at home and abroad in the past decade,with the results of cost-effectiveness analysis as the main basis.The article summarizes the differences in the economics of different classes of therapeutic drugs so as to provide reference for clinicians to select safe,effective and economical therapeutic regimens.

关 键 词：抑郁症 药物经济学 研究现状 成本- 效果分析 

分 类 号：R971.43[医药卫生—药品]